D'Amour P, Segre G V, Roth S I, Potts J T
J Clin Invest. 1979 Jan;63(1):89-98. doi: 10.1172/JCI109283.
After intravenous injection of [(125)I]-iodo-parathyroid hormone in the rat, uptake of the hormone was greatest in the liver and kidneys. Uptake was rapid, reaching a maximal concentration by 4 and 8 min, respectively. Extracts, prepared from both these organs at intervals soon after the injection of intact hormone, showed three main radioactive peaks when samples were subjected to gel filtration under protein-denaturing conditions. The first peak coeluted with intact hormone. The second eluted at a position corresponding to the carboxy-terminal fragments previously described in plasma, and the last eluted at the salt volume of the column. Microsequence analysis of the radioiodinated fragments, a method that has proved valuable for chemically defining the circulating fragments resulting from metabolism of injected hormone, showed that extracts of liver and kidney, prepared at 4 and 8 min after injection of the intact hormone, contained different fragments. The radioiodinated fragments in liver extracts were identical to those previously reported in the plasma of rats and dogs, fragments resulting principally from proteolysis between positions 33 and 34, and 36 and 37 of the intact hormone. Although the same fragments were also present in the kidneys, they constituted less than 15% of the amount present in the liver. More than 50% of the labeled renal fragments consisted of a peptide whose amino-terminal amino acid was position 39 of the intact hormone, a fragment not present in plasma. The rate of appearance of radioiodinated fragments that were chemically identical to those in plasma was more rapid in the liver than in plasma. Correlation of these chemical analyses with studies of the localization of (125)I by autoradiography showed that at the times when the intact hormone and the carboxy-terminal fragments comprised nearly all of the (125)I-labeled moieties in the tissues, the proximal convoluted tubules of the kidney and sinusoidal lining cells of the liver, which probably are Kupffer cells, contained the highest concentration of (125)I. Preferential localization of immunoreactive parathyroid hormone to these tissue sites also was shown by immunoperoxidase staining in studies with unlabeled hormone. Our results suggest that, unless multiple renal mechanisms are present for release of hormonal fragments, one of which releases the circulating fragments preferentially, the liver, rather than the kidney, is principally responsible for generating the carboxy-terminal fragments in plasma after injection of intact hormone, and the Kupffer cells may contain the enzymes that hydrolyze parathyroid hormone.
给大鼠静脉注射[(125)I]-碘甲状旁腺激素后,肝脏和肾脏对该激素的摄取量最大。摄取迅速,分别在4分钟和8分钟时达到最大浓度。在注射完整激素后不久,每隔一段时间从这两个器官制备提取物,当样品在蛋白质变性条件下进行凝胶过滤时,显示出三个主要放射性峰。第一个峰与完整激素共洗脱。第二个峰在与先前在血浆中描述的羧基末端片段相对应的位置洗脱,最后一个峰在柱的盐体积处洗脱。对放射性碘化片段进行微序列分析,该方法已被证明对于化学定义注射激素代谢产生的循环片段很有价值,结果表明,在注射完整激素后4分钟和8分钟制备的肝脏和肾脏提取物含有不同的片段。肝脏提取物中的放射性碘化片段与先前在大鼠和犬血浆中报道的片段相同,这些片段主要是由完整激素第33和34位以及36和37位之间的蛋白水解产生的。虽然肾脏中也存在相同的片段,但它们在肾脏中的含量不到肝脏中含量的15%。超过50%的标记肾脏片段由一种肽组成,其氨基末端氨基酸是完整激素的第39位,这是一种血浆中不存在的片段。与血浆中化学性质相同的放射性碘化片段在肝脏中的出现速度比在血浆中更快。这些化学分析与通过放射自显影对(125)I定位的研究相关联,结果表明,当完整激素和羧基末端片段几乎构成组织中所有(125)I标记部分时,肾脏的近端曲管和肝脏的窦状衬里细胞(可能是库普弗细胞)含有最高浓度的(125)I。在用未标记激素进行研究时,免疫过氧化物酶染色也显示免疫反应性甲状旁腺激素优先定位于这些组织部位。我们的结果表明,除非存在多种肾脏机制来释放激素片段,其中一种机制优先释放循环片段,否则在注射完整激素后,肝脏而非肾脏主要负责在血浆中产生羧基末端片段,并且库普弗细胞可能含有水解甲状旁腺激素的酶。